Prostate-Specific Antigen Flare Phenomenon During ²²³Ra-Dichloride Treatment for Bone Metastatic Castration-Resistant Prostate Cancer: A Case Report

Clin Genitourin Cancer. 2016 Oct;14(5):e529-e533. doi: 10.1016/j.clgc.2016.04.014. Epub 2016 Apr 27.

Authors

Giuseppe De Vincentis¹, Giulia Anna Follacchio², Viviana Frantellizzi¹, Mauro Liberatore¹, Francesco Monteleone¹, Enrico Cortesi³

Affiliations

¹ Department of Radiological Sciences, Oncology and Human Pathology, Nuclear Medicine Unit, Sapienza University of Rome, Rome, Italy.
² Department of Radiological Sciences, Oncology and Human Pathology, Nuclear Medicine Unit, Sapienza University of Rome, Rome, Italy. Electronic address: [email protected].
³ Department of Radiological Sciences, Oncology and Human Pathology, Medical Oncology Unit, Sapienza University of Rome, Rome, Italy.

PMID: 27212044
DOI: 10.1016/j.clgc.2016.04.014

No abstract available

Keywords: Bone metastases; PSA; Radionuclide therapy; Radium-223; mCRPC.

Publication types

Case Reports

MeSH terms

Adenocarcinoma / drug therapy*
Adenocarcinoma / secondary
Aged
Antineoplastic Agents / therapeutic use*
Bone Neoplasms / drug therapy*
Bone Neoplasms / secondary
Humans
Male
Prostate-Specific Antigen / blood*
Prostatic Neoplasms, Castration-Resistant / drug therapy*
Prostatic Neoplasms, Castration-Resistant / pathology
Radium / therapeutic use

Substances

Antineoplastic Agents
Radium-223
Prostate-Specific Antigen
Radium